Novartis Ventures, Sweden’s HealthCap, France’s Truffle Capital and London Technology Fund, have participated in a £8.65m funding round for British biotech company Immune Targeting Systems (ITS).
Morgan Stanley and Jefferies will guide GP on potential exit of Dutch digital agency
Investment director Matt Jacobs to lead mid-market GP’s sector team from London office
Kirk Kapital takes 50% in Danish modular building group alongside individual investors
Germany-based VC firm plans to invest 15-20% of its latest EUR 350m Digital West fund in the region